City of Hope Secures Landmark $23.7 Million Grant to Revolutionize Immunotherapy Resistance in Non-Small Cell Lung Cancer In a groundbreaking ...
Colorectal cancer (CRC) remains one of the most formidable challenges in oncology, ranking as the third most prevalent malignancy within ...
Patients battling advanced solid tumors have shown notably improved survival rates when their treatment was guided by genomic alterations identified ...
A groundbreaking study on circulating tumor DNA (ctDNA) testing for patients suffering from advanced breast cancer has emerged, yielding significant ...
